RVMD P/B: current value, 10-year range and year-by-year history
Cash & Leverage
RVMD's p/b is higher than 95% of the last 10 years.
P/B History
RVMD P/B by year
Yearly range of RVMD’s p/b from 2020 to 2026. Over the full period it ranged from 1.5 to 25.4, averaging 5.0.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 9.1 | 15.6 | 25.4 | 16.8 |
| 2025 | 2.7 | 4.6 | 9.6 | 9.3 |
| 2024 | 2.1 | 3.9 | 6.5 | 3.2 |
| 2023 | 2.0 | 3.0 | 4.5 | 3.7 |
| 2022 | 2.0 | 2.8 | 3.9 | 3.0 |
| 2021 | 2.6 | 4.0 | 7.6 | 3.1 |
| 2020 | 1.5 | 4.4 | 8.1 | 5.5 |
Get notified when RVMD P/B crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How much the market pays relative to the company's accounting net worth (assets minus liabilities). P/B < 1 means the market values the company below what the books say it owns.
Price / Book Value Per ShareMost useful for asset-heavy businesses: banks, insurers, REITs. A P/B near its historical low suggests the market is paying unusually little for the net assets.
- Goodwill and intangibles from acquisitions can inflate book value significantly — some analysts prefer tangible book value.
- Low P/B in technology or software companies is usually irrelevant: their value is in IP and people, not balance sheet assets.
Is RVMD P/B High or Low Right Now?
Revolution Medicines, Inc.'s P/B is currently 16.8, which is near historic high relative to its 10-year historical range. The 10-year median P/B for RVMD is approximately 3.5. See all RVMD valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.